NCT00252356View on ClinicalTrials.gov

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

468

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

May 31, 2007

Conditions

Major Depressive Disorder

Interventions

DRUG

SR58611A

Trial Locations (2)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Laval

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY